Form 4: Surgery Partners Executive Webb William Trenton Acquires Shares Through Restricted Stock Awards

Sentiment:

SEC Form 4 Filing


William Trenton Webb, an officer at Surgery Partners, Inc., acquired shares of common stock through restricted stock awards on March 4, 2025.

Summary

  • On March 4, 2025, William Trenton Webb, American Group President of Surgery Partners, Inc., acquired 12,605 shares of common stock at $23.80 per share through restricted stock awards.
  • Additionally, Webb acquired 3,781 shares of common stock at $23.80 per share through another grant of restricted stock awards.
  • Following these transactions, Webb directly owns 76,716 shares of Surgery Partners, Inc.
  • The first set of RSAs vest in three equal annual installments beginning on the first anniversary of the grant date.
  • The second set of RSAs vest on the first anniversary of the grant date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a standard insider transaction. The acquisition of shares by an executive is generally viewed as a positive sign, but it's a routine occurrence.

Positives

  • The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their investment in the company's stock.

Comparison to Industry Standards

  • Insider transactions are a common occurrence in publicly listed companies like Surgery Partners.
  • Similar filings are regularly made by executives at companies like HCA Healthcare, Tenet Healthcare, and Universal Health Services, reflecting their ongoing investment in their respective companies.
  • The vesting schedules of the restricted stock awards are typical for executive compensation packages in the healthcare industry.

Stakeholder Impact

  • Shareholders may view the executive's stock acquisition as a positive signal about the company's prospects.
  • Employees may see this as a sign of leadership's confidence in the company.
  • The impact on customers, suppliers, and creditors is likely minimal.

Key Dates

DateDescription
03/04/2025Date of transaction and grant date of restricted stock awards.
03/04/2026First anniversary of the grant date; vesting start date for the first set of RSAs and full vesting date for the second set of RSAs.
03/06/2025Date of signature for the Form 4 filing.

Keywords

Surgery Partners, SGRY, William Trenton Webb, restricted stock awards, Form 4, insider trading, beneficial ownership, equity securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.